Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their use

Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their use

US Patent 10301324 · Granted May 28, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-TMEM106B antibodies and methods of use thereof2025
Anti-TREM2 antibodies and methods of use thereof2023
Anti-TMEM106B antibodies and methods of use thereof2022
Anti-TREM2 antibodies and methods of use thereof2020
Anti-wall teichoic antibodies and conjugates2020
Compounds as opioid receptor modulators2019
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors2019
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors2019
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors2018
Ataxia telengiectasia and Rad3-related (ATR) protein kinase inhibitors2018
Gram-positive bacteria specific binding compounds2018
Azaquinazoline inhibitors of Atypical protein Kinase C2018